DocGo Announces Third Quarter 2026 Results and CEO Transition
DocGo reported Q3 2026 revenue of $73.4 million, up from $70.8 million a year ago, with GAAP gross margin improving to 29.7% from 20.0% and adjusted EBITDA loss narrowing to $3.2 million from $7.2 million. The board initiated a CEO search as Lee Bienstock's employment contract expires December 31, 2026; Bienstock stays on through the transition and at least March 31, 2027. Full-year 2026 revenue guidance was cut to roughly $300 million from $305-310 million due to deliberate elimination of unprofitable business lines, while adjusted EBITDA guidance of a $17-22 million loss was unchanged.
Key figures
- Revenue
- 73431205
- Guidance
- FY2026 revenue approximately $300 million (cut from $305-310 million); FY2026 adjusted EBITDA ($17-22) million loss, unchanged
- Revenue Yoy
- 3.7%
- Gaap gross margin
- 29.7%
- Unrestricted cash
- 19107209
- Adjusted gross margin
- 33.3%
- Mobile health revenue
- 20200000
- Medical transport revenue
- 53300000
- Gaap gross margin prior year
- 20.0%
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.